AtriCure (ATRC) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free ATRC Stock Alerts $23.14 +0.51 (+2.25%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 9:36 AM | marketbeat.comPanagora Asset Management Inc. Purchases 63,079 Shares of AtriCure, Inc. (NASDAQ:ATRC)Panagora Asset Management Inc. lifted its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 38.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 229,197 shares of the medical device company's stock after buMay 18 at 2:53 AM | americanbankingnews.comShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Drops By 6.9%May 16, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 6.9% in AprilAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 2,980,000 shares, a decline of 6.9% from the April 15th total of 3,200,000 shares. Based on an average daily volume of 789,000 shares, the short-interest ratio is currently 3.8 days.May 15, 2024 | businesswire.comAtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceMay 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Purchases 71,275 Shares of AtriCure, Inc. (NASDAQ:ATRC)TimesSquare Capital Management LLC increased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 7.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 976,110 shares of the medical device company's stocMay 6, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Price Up 6.7%AtriCure (NASDAQ:ATRC) Shares Up 6.7%May 4, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price TargetMay 4, 2024 | insidertrades.comAtriCure, Inc. (NASDAQ:ATRC) Insider Sells $36,135.00 in StockMay 3, 2024 | markets.businessinsider.comAtricure’s Strong Performance and Growth Potential Affirm Buy RatingMay 3, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Insider Justin J. Noznesky Sells 1,500 SharesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) insider Justin J. Noznesky sold 1,500 shares of AtriCure stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $24.09, for a total transaction of $36,135.00. Following the completion of the transaction, the insider now directly owns 71,284 shares in the company, valued at $1,717,231.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.May 3, 2024 | finance.yahoo.comAtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 3, 2024 | finance.yahoo.comThe past three years for AtriCure (NASDAQ:ATRC) investors has not been profitableMay 2, 2024 | markets.businessinsider.comAtricure’s Growth and Resilience Reinforce Buy RatingMay 2, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comCanaccord Genuity Group Cuts AtriCure (NASDAQ:ATRC) Price Target to $49.00Canaccord Genuity Group dropped their price target on AtriCure from $57.00 to $49.00 and set a "buy" rating for the company in a research note on Thursday.May 2, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSAtriCure (NASDAQ:ATRC - Get Free Report) released its quarterly earnings results on Wednesday. The medical device company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.02). The business had revenue of $108.90 million for the quarter, compared to the consensus estimate of $106.86 million. AtriCure had a negative net margin of 7.62% and a negative return on equity of 7.55%. The firm's revenue for the quarter was up 16.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.23) EPS.May 2, 2024 | markets.businessinsider.comAtriCure’s Strong Growth and Market Position Justify Buy RatingMay 2, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Hits New 1-Year Low on Analyst DowngradeAtriCure (NASDAQ:ATRC) Hits New 52-Week Low on Analyst DowngradeMay 2, 2024 | finance.yahoo.comAtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...May 1, 2024 | investorplace.comATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024May 1, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings GuidanceAtriCure (NASDAQ:ATRC) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.820--0.740 for the period, compared to the consensus estimate of -0.740. The company also issued revenue guidance of $459.0 millionillion-$466.0 millionillion, compared to the consensus estimate of $461.3 millionillion.May 1, 2024 | finance.yahoo.comAtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider LossesMay 1, 2024 | businesswire.comAtriCure Reports First Quarter 2024 Financial ResultsApril 30, 2024 | markets.businessinsider.comAtriCure is about to announce its earnings — here's what Wall Street expectsApril 30, 2024 | businesswire.comAtriCure to Participate in the 2024 Bank of America Securities Healthcare ConferenceApril 23, 2024 | msn.comAtriCure upgraded at Oppenheimer on valuationApril 23, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Upgraded at OppenheimerOppenheimer upgraded shares of AtriCure from a "market perform" rating to an "outperform" rating and set a $32.00 target price on the stock in a report on Tuesday.April 22, 2024 | finance.yahoo.comAtriCure, Inc. (ATRC) Stock Price, News, Quote & History - Yahoo FinanceApril 22, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Reaches New 1-Year Low at $22.36AtriCure (NASDAQ:ATRC) Reaches New 12-Month Low at $22.36April 20, 2024 | nasdaq.comFirst Week of June 21st Options Trading For AtriCure (ATRC)April 20, 2024 | investing.comAtriCure launches advanced cryoablation probe to expedite surgeriesApril 20, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Acquired by Knights of Columbus Asset Advisors LLCKnights of Columbus Asset Advisors LLC lifted its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 165.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 123,540 shares of the medical device companApril 18, 2024 | businesswire.comAtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain ManagementApril 17, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Trading 3.2% Higher AtriCure (NASDAQ:ATRC) Trading 3.2% HigherApril 16, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Reaches New 52-Week Low at $22.42AtriCure (NASDAQ:ATRC) Hits New 12-Month Low at $22.42April 15, 2024 | marketbeat.comShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Expands By 9.4%AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 3,250,000 shares, a growth of 9.4% from the March 15th total of 2,970,000 shares. Based on an average daily volume of 668,700 shares, the days-to-cover ratio is presently 4.9 days.April 10, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Reaches New 12-Month Low at $25.76AtriCure (NASDAQ:ATRC) Reaches New 52-Week Low at $25.76April 10, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $46.00 price target on shares of AtriCure in a research note on Wednesday.April 10, 2024 | businesswire.comAtriCure to Announce First Quarter 2024 Financial ResultsApril 9, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from BrokeragesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has been given a consensus recommendation of "Buy" by the five analysts that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month price target amongApril 3, 2024 | marketbeat.comInsider Selling: AtriCure, Inc. (NASDAQ:ATRC) Insider Sells 1,500 Shares of StockAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) insider Justin J. Noznesky sold 1,500 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $30.39, for a total transaction of $45,585.00. Following the transaction, the insider now owns 72,784 shares of the company's stock, valued at $2,211,905.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.April 2, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Hits New 12-Month Low at $27.86AtriCure (NASDAQ:ATRC) Hits New 52-Week Low at $27.86March 31, 2024 | marketbeat.comVanguard Group Inc. Boosts Position in AtriCure, Inc. (NASDAQ:ATRC)Vanguard Group Inc. lifted its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 0.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,689,883 shares of the medical device company's stock afterMarch 30, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 25.3% in MarchAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,970,000 shares, a growth of 25.3% from the February 29th total of 2,370,000 shares. Based on an average daily trading volume, of 618,100 shares, the days-to-cover ratio is currently 4.8 days.March 30, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Bought by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lifted its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 28.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 259,169 shares of the medical device compaMarch 28, 2024 | ca.finance.yahoo.comATRC May 2024 30.000 callMarch 26, 2024 | finance.yahoo.comAtriCure to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 22, 2024 | finance.yahoo.comAtriCure (ATRC) Declined due to Concerns Over Anti-Obesity DrugMarch 21, 2024 | insidertrades.comAtriCure, Inc. (NASDAQ:ATRC) Insider Sells $60,621.60 in StockMarch 20, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Price Down 3.8% on Insider SellingAtriCure (NASDAQ:ATRC) Stock Price Down 3.8% After Insider Selling Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… ATRC Media Mentions By Week ATRC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.470.42▲Average Medical News Sentiment ATRC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼63▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OFIX News Today SRDX News Today ATEC News Today IART News Today MDXG News Today AORT News Today FNA News Today KIDS News Today SILK News Today ATRI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
